|
|
|
| Clinical effect of Gamma Globulin as adjuvant treatment for severe adenoviral pneumonia in children |
| ZHOU Ming-jian CHEN Xiang-jian ZHUO Xiao-feng LIU Xue-feng▲ |
| Department of Paediatrics,Ningde Hospital Affiliated to Fujian Medical University,Fujian Province,Ningde 352100,China |
|
|
|
|
Abstract Objective To investigate the clinical effect of Gamma Globulin as adjuvant treatment for severe adenoviral pneumonia (SAP) in children. Methods The clinical data of 150 inpatients with SAP admitted in our hospital from May 2013 to May 2018 were retrospectively analyzed, they were divided into the Gamma Globulin group (75 patients) and the control group (75 patients)based on whether or not gamma globulin was used during treatment.The Gamma Globulin group was treated with adjuvant Gamma Globulin, the control group was treated with conventional therapy. The treatment effect, fever time, hospital stay, mechanical ventilation time, total incidence of adverse reactions and mortality were compared between the two groups. Results The total effective rate of the Gamma Globulin group was higher than that of the control group, the difference was statistically significant (P＜0.05). The fever time, hospitalization time, and mechanical ventilation time of the Gamma Globulin group were shorter than those of the control group, the differences were statistically significant (P＜0.05). There were no significant differences in the total incidence and mortality of adverse reactions between the two groups(P＞0.05).Conclusion Gamma Globulin adjuvant treatment of children SAP can improve the treatment effect of patients, shorten the fever time, hospitalization time and mechanical ventilation time of patients, without increasing the adverse reactions and mortality of the patients, which is worthy of clinical promotion and application.
|
|
|
|
|
|
| [1] |
黄淼，符州，罗蓉.儿童重症腺病毒肺炎诊疗进展[J].儿科药学杂志，2017，22（8）：49-52.
|
| [2] |
胡彦宏.儿童腺病毒肺炎的诊疗误区[J].中国临床医生杂志，2015，44（4）：3-5.
|
| [3] |
余莉，武志远，洪婕，等.儿童重症腺病毒肺炎的临床研究[J].现代生物医学进展，2016，16（19）：3713-3716.
|
| [4] |
Lai CY，Lee CJ，Lu CY，et al.Adenovirus serotype 3 and 7 infection with acute respiratory failure in children in Taiwan，2010-2011[J].PLoS One，2013，8（1）：e53614.
|
| [5] |
Lee J，Choi EH，Lee HJ.Comprehensive serotyping and epidemiology of human adenovirus isolated from the respiratory tract of Korean children over 17 consecutive years （1991-2007）[J].J Med Virol，2010，82（4）：624-631.
|
| [6] |
Low SY，Tan TT，Lee CHK，et al.Severe adenovirus pneumonia requiring extracorporeal membrane oxygenation support-Serotype 7 revisited[J].Respir Med，2013，107（11）：1810-1813.
|
| [7] |
中华人民共和国国家卫生健康委员会，国家中医药局.儿童社区获得性肺炎诊疗规范（2019年版）[J].中华临床感染病杂志，2019，12（1）：6-13.
|
| [8] |
Saettini F，Notarangelo LD，Biondi A，et al.Neutropenia，hypogammaglobulinemia，and pneumonia：a case of WHIM syndrome[J].Pediatr Int，2018，60 （3） ：318-319.
|
| [9] |
Lu MP，Ma LY，Zheng Q，et al.Clinical characteristics of adenovirus associated lower respiratory tract infection in children[J].World J Pediatr，2013，9（4）：346-349.
|
| [10] |
Chuang UYU，Chiu CH，Wong KS，et al.Severe adenovirus infection in children[J].J Microbiol Immunol Infect，2003，36（1）：37.
|
| [13] |
黄晗，卢红霞，宋春兰.IVIG 治疗儿童重症腺病毒肺炎的临床疗效和并发症观察[J].临床肺科杂志，2016，21（2）：271-273.
|
| [14] |
黄淼，罗蓉，符州.儿童重症腺病毒肺炎不良预后的危险因素分析[J].中国当代儿科杂志，2017，19（2）：159-162.
|
| [11] |
Hong JY，Lee HJ，Piedra PA，et al.Lower respiratory tract infections due to adenovirus in hospitalized Korean children：epidemiology，clinical feature，and prognosis[J].Clin Infect Dis，2001，32（10）：1423-1429.
|
| [12] |
Gong ST，Xia JQ，Lu JP，et al.Retrospective study of adenovirus in autopsied pulmonary tissue of pediatric fatal pneumonia in South China[J].BMC Infect Dis，2008，8（1）：122.
|
| [15] |
尹成军，薛国昌.大剂量丙种球蛋白对腺病毒肺炎患儿免疫功能的影响[J].中国医师进修杂志，2006，29（6）：28-29.
|
| [16] |
韩子明.静脉注射丙种球蛋白在儿童感染性疾病中的作用[J].实用儿科临床杂志，2009，24（9）：646-648.
|
| [17] |
陈艳黎，郑艳玲，徐卉年，等.人免疫球蛋白辅助治疗小儿重症肺炎有效性及安全性的Meta 分析[J].实用心脑肺血管病杂志，2017，25（1）：4-7.
|
| [18] |
李玉峰，云蕾，周丽江，等.静脉滴注丙种球蛋白治疗儿童过敏性紫癜不良反应观察及预防性护理[J].重庆医学，2017，46（3）：425-426.
|
|
|
|
